Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jayne

Showing results (331-340 of 341) with videos related to

Pageof 35
Sort By:
Annals of the Rheumatic Diseases|June 26, 2020
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitisRona M Smith, Rachel Bronwen Jones, Ulrich Specks, et al.
Kidney International Reports|January 22, 2026
A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative WorkshopLouise Oni, Rona Smith, Seza Ozen, et al.
The Lancet. Rheumatology|January 22, 2024
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort studyAlessandra Bettiol, Maria Letizia Urban, Roberto Padoan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Annals of the Rheumatic Diseases|November 26, 2016
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)Ronald van Vollenhoven, Alexandre Voskuyl, George Bertsias, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Lupus Science & Medicine|November 25, 2021
2021 DORIS definition of remission in SLE: final recommendations from an international task forceRonald F van Vollenhoven, George Bertsias, Andrea Doria, et al.
Annals of the Rheumatic Diseases|August 7, 2019
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosusMartin Aringer, Karen Costenbader, David Daikh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2019
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusMartin Aringer, Karen Costenbader, David Daikh, et al.
Annals of the Rheumatic Diseases|August 21, 2020
Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicitiesSindhu R Johnson, Ralph Brinks, Karen H Costenbader, et al.
Pageof 35

Showing results (331-340 of 341) with videos related to

Sort By:
Pageof 35
Annals of the Rheumatic Diseases|June 26, 2020
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitisRona M Smith, Rachel Bronwen Jones, Ulrich Specks, et al.
Kidney International Reports|January 22, 2026
A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative WorkshopLouise Oni, Rona Smith, Seza Ozen, et al.
The Lancet. Rheumatology|January 22, 2024
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort studyAlessandra Bettiol, Maria Letizia Urban, Roberto Padoan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational StudyAlessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Annals of the Rheumatic Diseases|November 26, 2016
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)Ronald van Vollenhoven, Alexandre Voskuyl, George Bertsias, et al.
Journal of Autoimmunity|March 27, 2025
Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative studyIrene Mattioli, Maria Letizia Urban, Roberto Padoan, et al.
Lupus Science & Medicine|November 25, 2021
2021 DORIS definition of remission in SLE: final recommendations from an international task forceRonald F van Vollenhoven, George Bertsias, Andrea Doria, et al.
Annals of the Rheumatic Diseases|August 7, 2019
2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosusMartin Aringer, Karen Costenbader, David Daikh, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 7, 2019
2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus ErythematosusMartin Aringer, Karen Costenbader, David Daikh, et al.
Annals of the Rheumatic Diseases|August 21, 2020
Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicitiesSindhu R Johnson, Ralph Brinks, Karen H Costenbader, et al.
Pageof 35